| Prev Close | 14.58 |
| Day Low/High | 13.85 / 14.87 |
| 52 Wk Low/High | 9.83 / 20.50 |
Aurinia Pharmaceuticals Inc. (AUPH)
14.00
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 127.45B |
| Market Cap | 1.86B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Stock Pickers Are Looking a Little Nervous, but This Market Needs Some Selling
The best thing that can happen to this market technically are some pullbacks.
The ATM Trade
My bread and butter trade is to find stocks with solid fundamental stories and then aggressively trade the volatility around core positions.
A 'Picker's' Delight: These Stocks Are on My Screen Today
The main themes are bitcoin, cannabis, stocks priced under $10, small biotechnology, and small-caps in general.
Profit-Taking Is Kicking In: Here Are Some Names on My Shopping List
Study those charts and be ready to act as things develop.
Shark Bites: Anatomy of a Trade - Aurinia Pharmaceuticals
This is how I am approaching the stock right now.
There's So Much Strong Market Action That It's Overwhelming
Small, aggressive traders are doing so well with the chasing that they are likely to continue for a while.
The Market Trend Is Still Our Friend
The folks that are waiting for the market collapse are going to have to keep waiting.
One Stock to Think About as We Finish Up 2020
Last-minute tax planning, window dressing, and positioning are dominating the rather quiet action.
My Top Six 2020 Stock Picks Gained an Average of 75%
A few of these names continue to look good in 2021.
Adding to an Old Favorite and Taking Some Profits in Cannabis
Aurinia Pharma has some positive catalysts, and I am taking partial gains in cannabis names as they remain strong.
We Have a Great Trading Environment Right Now
The primary focus is on the price action in individual stocks rather than macro-arguments or the technical condition of the indices.
Many Traders Are Locking in Gains as Traditional Holiday Trading Isn't There
The primary problem is that there was just too much wild speculative action on Monday and Tuesday.
There Isn't Any Immediate Positive Catalyst to Drive Stocks Higher
The best move right now is don't let losses grow and don't do much, if any, buying.
Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals
AUPH has two very large market opportunities for its voclosporin drug.
The Market Is a Feast of Opportunities
This great trading action comes in an environment with so many dramatic news headlines.
My Shopping List Amid This Selloff
Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.
Here's My Biotechnology Shopping List
Biotechnology is always high risk but the right plays move unlike anything else.
Hottest Sectors Start to Cool Off
Precious metals are an exception but electric vehicles and SPACs have lost their luster.
The Price Action Is Still Holding Up Relatively Well
There are opportunities but you better be selective and move fast.
4 Biotechnology Stocks I'm Buying on Weakness
It isn't just the bears that would welcome a pullback in this market.
6 Biotech Stocks I'm Looking to Buy as Hot Momentum Cools
My main focus right now is on stronger defense.
Here's How I'm Positioned and What I'm Holding
I see no reason to put much money into longer-term positions right now, but here are some of my biggest positions.
Update on My Top Picks for 2020, and a Look at Disney
I continue to follow the 6 names and believe several of them will recover well.
Small-Caps Are Finally Seeing Some Bottom Fishing
I believe this is just bounce action at this point and not a bottom, but I'm playing it.
How Am I Doing? An Update on My Top 6 Stock Picks for 2020
I've previously discussed why these six stocks are my top picks for 2020. I will periodically provide updates and discuss my strategy for trading them.
Trading Notes on 21 Stocks I Currently Own
Here are my takes on stocks in biotech and other companies I own right now.
My 5 Top Stock Picks for 2020: How I'm Trading Them Now
Given broader market weakness, this is a good time to take a look at these names and develop strategies.
The Dow Touches 29,000 and Sellers Step In
It is highly unlikely that the indices are going to roll over and go straight down from here.
